Global Lateral Epicondylitis Treatment Market Forecasts: 2019-2023 - Leading Players Are Bayer, GlaxoSmithKline, Johnson & Johnson Services, Merck Sharp & Dohme, and Pfizer - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 20, 2019--The “Global Lateral Epicondylitis Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
Analysts have predicted that the lateral epicondylitis treatment market will register a CAGR of over 3% by 2023.
Various government and non-government organizations are initiating certain programs to increase awareness among people and avoid delays in diagnosis. Hence, an increase in the number of organizations and institutes that raise awareness among people about lateral epicondylitis is expected to drive the growth of the global lateral epicondylitis treatment market during the forecast period.
Growing prevalence of risk factors for lateral epicondylitis
The growing prevalence of these medical conditions is the major risk factor for the development of lateral epicondylitis. The increase in the number of patients with these diseases may develop lateral epicondylitis. This, in turn, is expected to aid in the use of available treatments and anticipated treatments and drive the growth of the global lateral epicondylitis treatment market during the forecast period.
Lack of approved treatment
Lateral epicondylitis is a common problem with many available treatment options, but largely recommended treatment option is the combination of corticosteroids, physiotherapy, and bracing. However, there is no approved treatment for lateral epicondylitis. Therefore, the lack of approved treatments in the market for lateral epicondylitis is expected to hamper the growth of the global lateral epicondylitis treatment market during the forecast period.
The market appears to be moderately fragmented with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY TYPE
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
PART 12: VENDOR ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/research/8266kg/global_lateral?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190220005768/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Musculoskeletal Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/20/2019 12:47 PM/DISC: 02/20/2019 12:47 PM